Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease

NCT00792740 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
51
Enrollment
INDUSTRY
Sponsor class

Stopped As no safety warnings were detected, Interim analysis from the first 40 patients recommends to stop the trial for futility

Conditions

Interventions

Sponsor

Italfarmaco